Decision relating to various oncology medicines

13 June 2017 - PHARMAC is pleased to announce the approval of proposals for various oncology pharmaceuticals, including new listings ...

Read more →

Changes to the National Immunisation Schedule - meningococcal C conjugate vaccine

12 June 2017 - PHARMAC is pleased to announce a decision related to the National Immunisation Schedule (NIS) that will ...

Read more →

Proposal for various medicines in the neurology, immunology and nephrology therapeutic areas approved

12 June 2017 - PHARMAC is pleased to announce the approval of a proposal relating to certain medicines in the ...

Read more →

Proposal to list a range of orthopaedic implants and associated products supplied by Johnson & Johnson

6 June 2017 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated ...

Read more →

Proposal to amend listing in the National Immunisation Schedule – meningococcal C conjugate vaccine

23 May 2017 - PHARMAC is seeking feedback on one final proposal arising from an RFP for the supply of ...

Read more →

Proposal to list bendamustine hydrochloride

15 May 2017 - PHARMAC is seeking feedback on a proposal to list bendamustine hydrochloride (Ribomustin) through a provisional agreement ...

Read more →

HIV treatment proposal welcomed by New Zealand AIDS Foundation

8 May 2017 - The proposal to fund earlier access to HIV drugs has been welcomed by the New Zealand ...

Read more →

Proposal on various anti-infective medicines

8 May 2017 - PHARMAC is seeking feedback on a proposal to widen funded access to various pharmaceuticals in the ...

Read more →

Many New Zealanders to benefit from latest PHARMAC funding proposals

7 May 2017 - A series of 38 funding proposals across the breadth and scope of PHARMAC’s work has been ...

Read more →

Proposal for various medicines in the neurology, immunology and nephrology therapeutic areas

21 April 2017 - PHARMAC is seeking feedback on a proposal relating to certain medicines in the neurology, immunology and ...

Read more →

Listing on the Pharmaceutical Schedule of a range of orthopaedic implants and associated products with LMT Surgical Pty Ltd

5 April 2017 - PHARMAC is pleased to announce the approval of a listing agreement for the supply of orthopaedic ...

Read more →

Proposal to list 5-aminolevulinic acid hydrochloride (Gliolan) in the Hospital medicines list

31 March 2017 - PHARMAC is seeking feedback on a proposal to list 5-aminolevulinic acid hydrochloride (Gliolan) through a provisional ...

Read more →

Proposal to list a range of orthopaedic implants and associated products supplied by LMT Surgical Pty Ltd

9 March 2017 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated ...

Read more →

Additional listings on the Pharmaceutical Schedule of a range of orthopaedic implants and associated products with Smith and Nephew Limited

27 February 2017 - PHARMAC is pleased to announce the approval of an amendment to the trauma agreement with Smith ...

Read more →

Proposal to list orthopaedic hip and knee implants, cement and associated products on the Pharmaceutical Schedule

2 February 2017 - PHARMAC is seeking feedback on a proposal to list further ranges of orthopaedic implants and associated ...

Read more →